Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
World J Hepatol ; 9(16): 752-756, 2017 Jun 08.
Article in English | MEDLINE | ID: mdl-28652894

ABSTRACT

Spontaneous rupture is one of the most fatal complications of hepatic tumors such as hepatocellular carcinoma. In fact, many studies have shown that the in-hospital and 30-d mortality rates are as high as 25%-100%. Cholangiolocellular carcinoma (CoCC) is a rare primary hepatic tumor, usually small in size, that is thought to originate from the ductules and/or canals of Hering. Here, we present a case of spontaneous rupture of a CoCC that was successfully resected by radical surgery. Although CoCC is a rare primary hepatic tumor, it demonstrates certain specific clinical features, including a better prognosis than for other primary liver cancers, and thus should be distinguished from those other cancers. Moreover, CoCC can appear as a ruptured huge tumor, and when it does, radical hepatectomy can be an effective measure to achieve both absolute hemostasis and curability of tumor.

2.
Indian J Gastroenterol ; 36(3): 235-238, 2017 May.
Article in English | MEDLINE | ID: mdl-28555436

ABSTRACT

Recently, two conflicting articles about recurrence of hepatocellular carcinoma (HCC) after direct acting antivirals (DAA) against hepatitis C virus (HCV) were published. We investigated the relationship between DAA and HCC recurrence. Eligible patients were (1) history of HCC and treated curatively with interventions, and (2) interferon-free DAA therapy was initiated after eradication of HCC. We analyzed contributing factor for HCC recurrence. Ten out of 23 participants (43%) encountered recurrence of HCC. Age, sex, diabetes mellitus, fibrosis score, chemistry, and alpha-fetoprotein did not differ between patients with recurrence and patients without recurrence. The patients with recurrence had significantly higher values of antibody to hepatitis B core antigen (anti-HBc) than the patients without recurrence, 6.06±3.75 vs. 0.91±2.43 (p=0.0019). The relative risk of HCC recurrence comparing anti-HBc positive to negative was 5.2 (95% confidence interval 1.40 to 19.32). Odds ratio was 22.0 (95% confidence interval 2.5 to 191.1). We conclude that anti-HBc positivity was a strong contributing factor for HCC recurrence after DAA therapy.


Subject(s)
Antibodies, Viral/blood , Antiviral Agents/therapeutic use , Carcinoma, Hepatocellular/etiology , Hepatitis B Core Antigens/immunology , Hepatitis C, Chronic/drug therapy , Liver Neoplasms/etiology , Neoplasm Recurrence, Local , Aged , Aged, 80 and over , Antiviral Agents/administration & dosage , Carbamates , Carcinoma, Hepatocellular/blood , Carcinoma, Hepatocellular/therapy , Drug Therapy, Combination , Female , Hepatitis C, Chronic/complications , Humans , Imidazoles/administration & dosage , Liver Neoplasms/blood , Liver Neoplasms/therapy , Male , Pyrrolidines , Retrospective Studies , Ribavirin/administration & dosage , Risk Factors , Sofosbuvir/administration & dosage , Valine/analogs & derivatives
3.
J Thorac Dis ; 5(1): 87-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23372954

ABSTRACT

A single pleural space can lead to serious simultaneous bilateral pneumothorax in cases of congenital or acquired pleuro-pleural communication. Here we report a 35-year-old man with bilateral pneumothorax. Chest computed tomography scans revealed a small air space between the esophagus and aorta, suggesting pleuro-pleural communication. Bilateral thoracoscopic bullectomy was performed. Repeated inspection revealed a 2-cm-long pleural window between the aorta and esophagus, which was closed with a collagen patch. Although congenital pleuro-pleural communication has been regarded as rare, as many as nine patients have been reported (if suspected cases are included). The lower middle mediastinum should be carefully inspected.

4.
J Hepatobiliary Pancreat Surg ; 11(6): 422-5, 2004.
Article in English | MEDLINE | ID: mdl-15619019

ABSTRACT

Hemosuccus pancreaticus (HP) is a rare cause of gastrointestinal bleeding, usually due to rupture of a visceral artery aneurysm in chronic pancreatitis. Other causes of HP are rare. We present a case of HP which occurred in a patient with chronic calcifying pancreatitis and a pancreatic pseudocyst documented by ultrasonography and computed tomography. With detectable fresh blood in the descending duodenum, an aneurysm in the pancreatic head was revealed by superior mesenteric angiography as the suspected origin of intermittent bleeding from the pancreatic duct. Because an artery feeding the pseudocyst could not be identified, angiographic embolization was not possible. Surgical resection or ligation was difficult by laparotomy; therefore, intraoperative packing of the pseudocyst with absorbable gelatin sponges was achieved via a cannula through a directly punctured site in the pseudocyst wall. The patient has been followed for 4.25 years with no further episodes of HP. It is possible that the packing of a pancreatic pseudocyst with gelatin sponges is a method that can be used in similar cases, where control of hemostasis is the primary concern. The packing of a pancreatic pseudocyst with gelatin sponges is a technique that can be performed not only via laparotomy but also via laparoscopy or concomitant angiography and ultrasonography.


Subject(s)
Aneurysm, False/complications , Gastrointestinal Hemorrhage/etiology , Pancreatic Pseudocyst/complications , Pancreatic Pseudocyst/surgery , Pancreatitis/complications , Chronic Disease , Humans , Male , Middle Aged , Pancreatic Ducts , Rupture, Spontaneous , Tampons, Surgical
5.
Gan To Kagaku Ryoho ; 31(11): 1882-4, 2004 Oct.
Article in Japanese | MEDLINE | ID: mdl-15553747

ABSTRACT

We examined our results of liver cryosurgery for synchronized liver metastasis from colorectal cancer. Twelve patients whose prognosis after the cryosurgery was clear were eligible. All of the patients received not only a resection of the colorectal primary lesion, but they also received a cryosurgery for liver metastases under the same laparotomy. These patients had been treated in this manner from 1981 to 1987. Ten of the 12 patients died from recurrent cancer. The range in survival time of 12 cases was from 6 months to 117 months, and the average survival length was 25.4 months. The examination of the results suggested that there were no cryosurgery induced anti-immunological response observed among the patients. The survival lengths of the patients with untreated cancer were good.


Subject(s)
Colorectal Neoplasms/pathology , Cryosurgery , Hepatectomy/methods , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Adult , Aged , Colorectal Neoplasms/surgery , Female , Humans , Liver Neoplasms/immunology , Liver Neoplasms/mortality , Male , Middle Aged , Survival Rate
6.
J Surg Oncol ; 88(4): 256-60, 2004 Dec 15.
Article in English | MEDLINE | ID: mdl-15565592

ABSTRACT

BACKGROUND AND OBJECTIVES: This report describes a modified method of implanting a catheter-port system for hepatic arterial infusion chemotherapy (HAIC) that combines interventional radiological (IVR) and laparotomic approaches. METHODS AND RESULTS: In patients, scheduled for HAIC and laparotomic surgery, we now employ a modified method of implanting the catheter-port system. In our method, an IVR approach is used to implant the catheter-port, and arterial occlusions are primarily carried out using a laparotomic approach. Following celiac and superior mesenteric arteriographies, a tapered microcatheter with a side hole is inserted by a catheter exchange method. The catheter tip is advanced far into the gastroepiploic artery via the gastroduodenal artery (GDA). The side hole is located at the orifice of the proper hepatic artery, and its location is confirmed by injection of contrast media. The microcatheter is connected to the port, and the port is buried in the subcutaneous pocket. During the laparotomy stage, the GDA lumen and the catheter lumen are clipped, and the right gastric artery (RGA) and all small branches supplying the stomach, duodenum, and pancreas are ligated. Among the 13 patients successfully implanted with a port-catheter system using our combined approach, no patients had hepatic artery occlusion or occlusion of the catheter system. CONCLUSIONS: Initial results from a study of a new method of implanting a microcatheter-port system in the hepatic artery using combined IVR and laparotomic approaches suggest that this method may enable operators to avoid complicated selective coiling and may lower the incidence of hepatic artery occlusion in patients receiving long-term HAIC.


Subject(s)
Catheterization, Peripheral/instrumentation , Catheters, Indwelling , Coated Materials, Biocompatible , Liver Neoplasms/drug therapy , Epigastric Arteries/surgery , Hepatic Artery , Humans , Infusions, Intra-Arterial , Laparoscopy , Laparotomy , Liver Neoplasms/surgery
7.
Gan To Kagaku Ryoho ; 29(12): 2104-7, 2002 Nov.
Article in Japanese | MEDLINE | ID: mdl-12484013

ABSTRACT

Hepatectomy and intraarterial chemotherapy for liver metastasis from colorectal cancer have been performed in our department. Intraarterial infusion chemotherapy has also been performed for unresectable liver metastasis. One hundred twenty-seven cases of liver metastasis from colorectal cancer were studied. The cases were divided into groups according to radicability of the original colorectal cancer, whether or not hepatectomy was performed, and whether or not they received intraarterial chemotherapy. Group I is cur C of origin. Group II is cur A or B without hepatectomy. Group III is cur A or B with hepatectomy. Each group was divided into a group without intraarterial chemotherapy (A) and a group with it (B). IA 23 cases, IB 13 cases, IIA 14 cases, IIB 21 cases, IIIA 28 cases, and IIIB 28 cases. The survival rate of group III was better than that of group II. The survival rate of group II was better than that of group I. There was no significant difference in survival rates between IA and IB. The survival rate of group IIB was significantly better than that of group IIA. The survival rate of group IIIB was significantly better than that of group III A. Hepatectomy and intraarterial chemotherapy after hepatectomy for liver metastasis from colorectal cancer were effective.


Subject(s)
Colorectal Neoplasms/pathology , Hepatectomy , Infusions, Intra-Arterial , Liver Neoplasms/secondary , Liver Neoplasms/therapy , Antimetabolites, Antineoplastic/administration & dosage , Fluorouracil/administration & dosage , Humans , Liver Neoplasms/mortality , Survival Rate
8.
Gan To Kagaku Ryoho ; 29(4): 599-602, 2002 Apr.
Article in Japanese | MEDLINE | ID: mdl-11977546

ABSTRACT

A 69-year-old female with unresectable hepatocellular carcinoma was treated with continuous arterial infusion of low-dose cisplatin (10 mg/body/day) and 5-fluorouracil (250 mg/body/day). The regimen was continued for 5 days then discontinued for 2 days, and repeated for 4 weeks. The portal tumor thrombus almost disappeared and HCC was smaller than before chemotherapy. Tumor marker (AFP and PIVKA-II) decreased remarkably. As tumor markers increased again 2 months later, the same regimen chemotherapy was performed once more. The patient was treated with arterial chemotherapy as an outpatient. The present case of hepatocellular carcinoma with portal tumor thrombus was effectively treated by arterial infusion chemotherapy with low dose cisplatin and 5-fluorouracil.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms/drug therapy , Neoplastic Cells, Circulating/drug effects , Portal System/pathology , Aged , Cisplatin/administration & dosage , Drug Administration Schedule , Female , Fluorouracil/administration & dosage , Hepatic Artery , Humans , Infusions, Intra-Arterial
SELECTION OF CITATIONS
SEARCH DETAIL
...